Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SUNDSundance Strategies, Inc.

OTC · CIK 0001171838
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6411 Insurance Agents, Brokers & Service
FY end0331
XBRL facts368

Identity from submissions API

NameSundance Strategies, Inc.
CIK0001171838
TickersSUND
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6411 Insurance Agents, Brokers & Service
EIN880515333
LEI—
Fiscal year end0331
State of incorporationNV NV
Phone801-705-8968
Website—
Investor website—
Owner org02 Finance
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • JAVA EXPRESS INC (2002-04-26T04:00:00.000Z → 2013-04-16T04:00:00.000Z)
Business address
4626 NORTH 300 WEST, SUITE 365
PROVO
UT
84604
UT
Mailing address
4626 NORTH 300 WEST, SUITE 365
PROVO
UT
84604
UT

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

225 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q 10-Q 0001493152-26-052304 000-50547 261559984 34 3973583 1 1
2026-08-13 10-Q 10-Q 0001493152-26-037703 000-50547 261272483 34 2748985 1 1
2026-06-29 10-K 10-K 0001493152-26-031046 000-50547 261135173 34 10137037 1 1
2026-02-17 10-Q 10-Q 0001493152-26-007030 000-50547 26639212 34 5073621 1 1
2025-11-13 10-Q 10-Q 0001493152-25-022380 000-50547 251479478 34 3032414 1 1
2025-08-13 10-Q 10-Q 0001641172-25-023411 000-50547 251210739 34 2640081 1 1
2025-06-30 10-K 10-K 0001641172-25-017143 000-50547 251092261 34 4783039 1 1
2025-02-14 10-Q form10-q.htm 0001493152-25-006815 000-50547 25627726 34 2865640 1 1
2024-11-08 10-Q form10-q.htm 0001493152-24-044334 000-50547 241441713 34 2741453 1 1
2024-08-13 10-Q form10-q.htm 0001493152-24-031412 000-50547 241198528 34 2896952 1 1
2024-07-01 10-K form10-k.htm 0001493152-24-025765 000-50547 241090049 34 5253247 1 1
2024-02-14 10-Q form10-q.htm 0001493152-24-006487 000-50547 24636021 34 3199795 1 1
2023-11-14 10-Q form10-q.htm 0001493152-23-040910 000-50547 231403898 34 3019619 1 1
2023-08-14 10-Q form10-q.htm 0001493152-23-028534 000-50547 231171067 34 4115352 1 1
2023-06-29 10-K form10-k.htm 0001493152-23-022963 000-50547 231058535 34 9214026 1 1
2023-02-14 10-Q form10-q.htm 0001493152-23-004805 000-50547 23628419 34 2865859 1 1
2022-11-14 10-Q form10-q.htm 0001493152-22-032102 000-50547 221386338 34 2438669 1 1
2022-08-15 10-Q form10-q.htm 0001493152-22-022941 000-50547 221166441 34 2309398 1 1
2022-06-29 10-K form10-k.htm 0001493152-22-018095 000-50547 221054621 34 7779419 1 1
2022-02-14 10-Q form10-q.htm 0001493152-22-004540 000-50547 22634634 34 5459781 1 1
2021-11-15 10-Q form10-q.htm 0001493152-21-028498 000-50547 211409364 34 2897895 1 1
2021-08-16 10-Q form10-q.htm 0001493152-21-020217 000-50547 211179196 34 2328785 1 1
2021-06-29 10-K form10-k.htm 0001493152-21-015565 000-50547 211058727 34 2436054 1
2021-04-15 8-K form8-k.htm 8.01,9.01 0001493152-21-008794 000-50547 21827213 34 84958
2021-02-16 10-Q form10-q.htm 0001493152-21-003741 000-50547 21631647 34 1781830 1
2020-11-16 10-Q form10-q.htm 0001493152-20-021719 000-50547 201317797 34 1700218 1
2020-09-02 10-K/A form10-ka.htm 0001493152-20-017106 000-50547 201155332 34 55214
2020-08-19 10-Q form10-q.htm 0001493152-20-016284 000-50547 201116753 34 2410893 1
2020-08-14 NT 10-Q formnt10q.htm 0001493152-20-015873 000-50547 201105587 34 29981
2020-08-11 10-K form10-k.htm 0001493152-20-015137 000-50547 201090648 34 2330591 1
2020-06-29 8-K form8-k.htm 8.01 0001493152-20-012163 000-50547 20998911 34 29493
2020-02-19 10-Q form10-q.htm 0001493152-20-002708 000-50547 20628507 34 1559828 1
2020-02-19 10-Q form10-q.htm 0001493152-20-002706 000-50547 20628420 34 1614972 1
2020-02-19 10-Q form10-q.htm 0001493152-20-002704 000-50547 20628227 34 1341797 1
2020-02-14 NT 10-Q formnt10-q.htm 0001493152-20-002315 000-50547 20616360 34 32719
2020-01-16 10-K form10-k.htm 0001493152-20-000649 000-50547 20529224 34 2782139 1
2019-11-25 10-Q form10-q.htm 0001493152-19-018382 000-50547 191247084 34 1752433 1
2019-11-15 10-Q form10-q.htm 0001493152-19-017692 000-50547 191223207 34 1671600 1
2019-10-24 10-Q form10-q.htm 0001493152-19-015907 000-50547 191166295 34 1633038 1
2019-10-16 10-K form10-k.htm 0001493152-19-015587 000-50547 191153391 34 3248026 1
2019-04-25 10-Q form10-q.htm 0001493152-19-005960 000-50547 19768377 34 2067553 1
2019-04-25 10-Q form10-q.htm 0001493152-19-005959 000-50547 19768357 34 1967491 1
2019-04-08 10-Q FORM 10-Q 0000891092-19-004397 000-50547 19736246 34 1789804 1
2018-12-10 8-K sundance8k_121018.htm 1.01,3.02,5.02 0000912282-18-000161 000-50547 181226182 34 24874
2018-06-11 8-K FORM 8-K 1.01,9.01 0000891092-18-004751 000-50547 18891654 34 293114
2018-06-05 8-K FORM 8-K 2.06 0000891092-18-004684 000-50547 18882197 34 12895
2018-04-18 8-K FORM 8-K 4.01,9.01 0001580957-18-000202 000-50547 18761208 34 22602
2018-04-12 10-K FORM 10-K 0001580957-18-000172 000-50547 18752685 34 4070801 1
2018-01-22 8-K sundance8k_012218.htm 4.01,9.01 0000912282-18-000019 000-50547 18540379 34 40054
2018-01-12 8-K sundance8k_011118.htm 5.02,7.01,9.01 0000912282-18-000011 000-50547 18525808 34 608234
2017-06-30 NT 10-K NT 10-K 0001580957-17-000520 000-50547 17942014 34 17472
2017-04-17 10-Q FORM 10-Q 0001580957-17-000296 000-50547 17763421 34 1854049 1
2017-02-09 NT 10-Q NT 10-Q 0001580957-17-000054 000-50547 17587992 34 17197
2016-11-09 10-Q FORM 10-Q 0001580957-16-000932 000-50547 161984981 34 1408621 1
2016-09-23 8-K sundance8k_092316.htm 5.07,7.01 0000912282-16-000843 000-50547 161900360 34 45703
2016-08-09 10-Q FORM 10-Q 0001580957-16-000785 000-50547 161819219 34 1280195 1
2016-07-29 DEF 14A sundance_def14a.htm 0000912282-16-000793 000-50547 161795075 34 393005
2016-07-27 8-K sundance8k_072616.htm 4.01,9.01 0000912282-16-000789 000-50547 161786878 34 92557
2016-06-14 10-K FORM 10-K 0001580957-16-000709 000-50547 161713797 34 4314357 1
2016-05-06 8-K sundance8k_05042016.htm 7.01,9.01 0000912282-16-000706 000-50547 161625296 34 63258 1
2016-02-09 10-Q sundance10-q_12312015.htm 0000912282-16-000555 000-50547 161398814 34 3229797 1
2015-12-01 8-K CURRENT REPORT ON FORM 8-K DATED DECEMBER 1, 2015 7.01,9.01 0001010412-15-000201 000-50547 151261895 34 29799
2015-11-10 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2015 0001548123-15-000377 000-50547 151216896 34 3097417 1
2015-11-09 NT 10-Q REQUEST FOR AN EXTENSION OF TIME TO FILE OUR QUARTERLY REPORT ON FORM 10-Q FOR T 0001010412-15-000185 000-50547 151216865 34 9527
2015-09-28 8-K CURRENT REPORT ON FORM 8-K DATED SEPTEMBER 28, 2015 7.01,9.01 0001010412-15-000164 000-50547 151127559 34 147440
2015-08-10 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED JUNE 30, 2015 0001010412-15-000125 000-50547 151041751 34 5117062 1
2015-07-22 3 PRIMARY DOCUMENT 0001010412-15-000109 4501
2015-07-17 4 PRIMARY DOCUMENT 0001010412-15-000106 8394
2015-06-25 4 PRIMARY DOCUMENT 0001010412-15-000088 10510
2015-06-24 8-K CURRENT REPORT ON FORM 8-K DATED JUNE 24, 2015 7.01,9.01 0001010412-15-000087 000-50547 15949982 34 29164
2015-06-15 10-K ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED MARCH 31, 2015 0001010412-15-000084 000-50547 15932487 34 8310951 1
2015-06-04 3 PRIMARY DOCUMENT 0001010412-15-000077 5393
2015-04-07 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A-2 DATED DECEMBER 5, 2014 1.01,9.01 0001010412-15-000050 000-50547 15756355 34 33886
2015-03-10 8-K CURRENT REPORT ON FORM 8-K DATED MARCH 10, 2015 7.01,9.01 0001010412-15-000040 000-50547 15688394 34 52415
2015-03-06 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A DATED DECEMBER 5, 2014 1.01,9.01 0001010412-15-000039 000-50547 15680503 34 28711
2015-02-17 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED DECEMBER 31, 2014 0001010412-15-000030 000-50547 15620693 34 2764346 1
2015-02-13 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A-2 DATED DECEMBER 31, 2014 5.02 0001010412-15-000029 000-50547 15611395 34 20902
2015-02-11 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A-1 DATED DECEMBER 31, 2014 5.02 0001010412-15-000027 000-50547 15598844 34 20883
2015-01-15 8-K CURRENT REPORT ON FORM 8-K DATED JANUARY 12, 2015 5.02 0001010412-15-000009 000-50547 15530286 34 21304
2015-01-12 8-K CURRENT REPORT ON FORM 8-K DATED JANUARY 12, 2015 7.01,9.01 0001010412-15-000008 000-50547 15522344 34 51621
2015-01-06 8-K CURRENT REPORT ON FORM 8-K DATED DECEMBER 31, 2014 5.02 0001010412-15-000004 000-50547 15509456 34 20547
2015-01-06 4 PRIMARY DOCUMENT 0001010412-15-000003 7777
2014-12-08 8-K CURRENT REPORT ON FORM 8-K DATED DECEMBER 5, 2014 1.01,7.01,9.01 0001010412-14-000203 000-50547 141272981 34 167029
2014-11-14 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2014 0001010412-14-000185 000-50547 141222660 34 2623036 1
2014-08-14 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED JUNE 30, 2014 0001010412-14-000139 000-50547 141041980 34 2260084 1
2014-07-21 8-K CURRENT REPORT ON FORM 8-K DATED JULY 21, 2014 7.01,9.01 0001010412-14-000127 000-50547 14984702 34 144566
2014-07-21 10-K/A AMENDED ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED MARCH 31, 2014 0001010412-14-000126 000-50547 14984674 34 4948601 1
2014-07-16 10-K ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED MARCH 31, 2014 0001010412-14-000125 000-50547 14976736 34 852688
2014-07-10 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A-5 DATED JUNE 7, 2013 1.01,2.01,3.02,8.01,9.01 0001010412-14-000121 000-50547 14969419 34 103585
2014-06-30 NT 10-K REQUEST FOR AN EXTENSION OF TIME TO FILE OUR ANNUAL REPORT ON FORM 10K FOR THE Y 0001010412-14-000115 000-50547 14947861 34 9241
2014-05-27 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A-3 DATED JUNE 7, 2013 1.01,2.01,3.02,8.01,9.01 0001010412-14-000110 000-50547 14870513 34 80829
2014-05-21 4 PRIMARY DOCUMENT 0001010412-14-000107 5733
2014-05-08 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A-3 DATED JUNE 7, 2013 1.01,2.01,3.02,9.01 0001010412-14-000090 000-50547 14824963 34 78643
2014-05-05 8-K CURRENT REPORT ON FORM 8-K DATED JANUARY 14, 2014 7.01,9.01 0001010412-14-000089 000-50547 14813294 34 134457
2014-05-02 UPLOAD filename1.pdf 0000000000-14-022341 36351
2014-02-14 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED DECEMBER 31, 2013 0001010412-14-000019 000-50547 14617488 34 3531556 1
2014-01-27 CORRESP filename1.htm 0001010412-14-000006 9459
2014-01-14 8-K CURRENT REPORT ON FORM 8-K DATED JANUARY 14, 2014 7.01,9.01 0001010412-14-000002 000-50547 14527703 34 14030
2013-12-23 D/A xslFormDX01/primary_doc.xml 06b 0001010412-13-000306 021-197999 131293963 33 7926
2013-12-16 UPLOAD filename1.pdf 0000000000-13-068176 42865
2013-11-27 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A-4 DATED MARCH 29, 2013 1.01,3.02,4.01,5.01,5.02,5.06,9.01 0001010412-13-000298 000-50547 131247061 34 916770
2013-11-14 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2013 0001010412-13-000280 000-50547 131220283 34 13714963 1
2013-11-14 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A-2 DATED JUNE 7, 2013 1.01,2.01,3.02,9.01 0001010412-13-000275 000-50547 131219033 34 469614
2013-11-12 8-K CURRENT REPORT ON FORM 8-K DATED NOVEMBER 12, 2013 7.01,9.01 0001010412-13-000273 000-50547 131208445 34 15627
2013-10-24 8-K f8kcurrentreportlwb102413.htm 5.02,7.01,9.01 0001010412-13-000267 000-50547 131167689 34 15739
2013-09-26 UPLOAD filename1.pdf 0000000000-13-053331 40443
2013-09-19 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A-1 DATED JUNE 7, 2013 1.01,2.01,3.02,9.01 0001010412-13-000261 000-50547 131105479 34 680966
2013-09-12 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A-3 DATED MARCH 29, 2013 1.01,3.02,4.01,5.01,5.02,5.06,9.01 0001010412-13-000244 000-50547 131094790 34 1119854
2013-08-12 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED JUNE 30, 2013 0001010412-13-000226 000-50547 131028978 34 3816229 1
2013-07-26 UPLOAD filename1.pdf 0000000000-13-041124 151733
2013-07-16 10-K ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED MARCH 31, 2013 0001010412-13-000195 000-50547 13969955 34 3934065 1
2013-07-12 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A-2 DATED MARCH 29, 2013 1.01,3.02,4.01,5.01,5.02,5.06,9.01 0001010412-13-000191 000-50547 13966553 34 755370
2013-07-01 NT 10-K REQUEST FOR AN EXTENSION OF TIME TO FILE OUR ANNUAL REPORT ON FORM 10K FOR THE Y 0001010412-13-000177 000-50547 13944261 34 9079
2013-06-20 8-K CURRENT REPORT ON FORM 8-K DATED JUNE 7, 2013 1.01,2.01,3.02,9.01 0001010412-13-000162 000-50547 13923823 34 692738
2013-06-13 D xslFormDX01/primary_doc.xml 06 0001010412-13-000159 021-197999 13912207 33 7766
2013-06-11 UPLOAD filename1.pdf 0000000000-13-031698 172329
2013-06-10 8-K CURRENT REPORT ON FORM 8-K DATED JUNE 10, 2013 7.01,9.01 0001010412-13-000158 000-50547 13902659 34 14690
2013-05-24 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A-1 DATED MARCH 29, 2013 1.01,3.02,4.01,5.01,5.02,5.06,9.01 0001010412-13-000149 000-50547 13869601 34 2416043
2013-05-03 UPLOAD filename1.pdf 0000000000-13-024288 206165
2013-04-17 8-K 8-K CURRENT REPORT DATED APRIL 17, 2013 5.03,7.01,9.01 0001010412-13-000112 000-50547 13766829 34 15917
2013-04-16 SC 13G SCHEDULE 13G SMARTRADE CONSULTING INC. 0001010412-13-000108 005-81838 13763469 34 21739
2013-04-11 3 PRIMARY DOCUMENT 0001010412-13-000102 5118
2013-04-11 SC 13D SCHEDULE 13D FOR TY MATTINGLY 0001010412-13-000101 005-81838 13755326 34 15529
2013-04-10 D xslFormDX01/primary_doc.xml 06 0001010412-13-000100 021-194762 13753048 33 7529
2013-04-09 SC 13D SCHEDULE 13D FOR MITCHELL D. BURTON 0001010412-13-000099 005-81838 13750318 34 15556
2013-04-09 3 PRIMARY DOCUMENT 0001010412-13-000098 5076
2013-04-08 SC 13D/A SCHEDULE 13D/A FOR MARK SANSOM 0001548123-13-000128 005-81838 13748871 34 15533
2013-04-08 4 PRIMARY DOCUMENT 0001010412-13-000097 2816
2013-04-08 3 PRIMARY DOCUMENT 0001010412-13-000096 3964
2013-04-08 SC 13D/A SCHEDULE 13D/A FOR KELLEY TRIMBLE 0001010412-13-000095 005-81838 13748345 34 15604
2013-04-08 4 PRIMARY DOCUMENT 0001010412-13-000094 5656
2013-04-08 4 PRIMARY DOCUMENT 0001010412-13-000093 2829
2013-04-08 3 PRIMARY DOCUMENT 0001010412-13-000092 3967
2013-04-05 8-K 8-K CURRENT REPORT DATED MARCH 29, 2013 1.01,3.02,4.01,5.01,5.02,5.06,9.01 0001010412-13-000091 000-50547 13745082 34 4422719
2013-03-29 8-K CURRENT REPORT ON FORM 8-K DATED MARCH 29, 2013 7.01,9.01 0001010412-13-000088 000-50547 13728093 34 12074
2013-02-14 10-Q DECEMBER 31, 2012 10-Q 0001078782-13-000317 000-50547 13607835 34 1483780 1
2012-11-27 8-K CURRENT REPORT ON FORM 8-K DATED NOVEMBER 12, 2012 8.01 0001010412-12-000404 000-50547 121225280 34 7472
2012-11-15 8-K CURRENT REPORT ON FORM 8-K DATED NOVEMBER 12, 2012 5.07 0001010412-12-000393 000-50547 121206183 34 8025
2012-11-13 10-Q/A SEPTMEBR 30, 2012 10-Q/A 0001078782-12-002793 000-50547 121196765 34 1212768 1
2012-11-13 4 PRIMARY DOCUMENT 0001010412-12-000382 3750
2012-11-09 10-Q SEPTMEBR 30, 2012 10-Q 0001078782-12-002789 000-50547 121194805 34 194391
2012-11-08 3 PRIMARY DOCUMENT 0001010412-12-000378 2819
2012-10-30 DEF 14A DEFINITIVE PROXY STATEMENT 0001010412-12-000372 000-50547 121167558 34 72360
2012-10-18 8-K/A AMENDED CURRENT REPORT ON FORM 8-K/A DATED OCTOBER 15, 2012 4.01,5.02,9.01 0001010412-12-000367 000-50547 121150198 34 14960
2012-10-17 PRE 14A PRELIMINARY PROXY STATEMENT 0001010412-12-000365 000-50547 121148489 34 72359
2012-10-17 8-K CURRENT REPORT ON FORM 8-K DATED OCTOBER 15, 2012 4.01,5.02,9.01 0001010412-12-000364 000-50547 121148347 34 15626
2012-08-10 10-Q JUNE 30, 2012 10-Q 0001078782-12-001966 000-50547 121024417 34 1368775 1
2012-07-16 10-K MARCH 31, 2012 10-K 0001078782-12-001796 000-50547 12964291 34 1458343 1
2012-06-29 NT 10-K 03/31/12 10-K EXTENSION 0001078782-12-001708 000-50547 12934820 34 14663
2012-02-09 10-Q DECEMBER 31, 2011 10Q 0001078782-12-000337 000-50547 12585654 34 1031960 1
2011-11-14 10-Q FORM 10-Q QUARTERLY REPORT 0001078782-11-003251 000-50547 111200374 34 985892 1
2011-08-15 10-Q QUARTERLY REPORT ON FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2011 0001023175-11-000482 000-50547 111035948 34 1023584 1
2011-06-28 10-K ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED MARCH 31, 2011 0001023175-11-000355 000-50547 11935055 34 1437502 1
2011-02-14 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE PERIOD ENDED DECEMBER 31, 2010 0001023175-11-000050 000-50547 11605798 34 279819
2010-12-08 8-K 8-K CURRENT REPORT DATED DECEMBER 8, 2010 5.03,9.01 0001010412-10-000351 000-50547 101239288 34 98807
2010-11-10 10-Q QUARTERLY REPORT ON FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2010 0001023175-10-000314 000-50547 101181125 34 277881
2010-10-18 DEF 14C DEFINITIVE INFORMATION STATEMENT 0001010412-10-000295 000-50547 101128063 34 81087
2010-10-04 PRER14C REVISED PRELIMINARY INFORMATION STATEMENT 0001010412-10-000285 000-50547 101106721 34 80025
2010-08-11 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE PERIOD ENDED JUNE 30, 2010 0001023175-10-000230 000-50547 101007393 34 266559
2010-08-03 PRE 14C PRELIMINARY INFORMATION STATEMENT 0001023175-10-000217 000-50547 10986696 34 63286
2010-08-03 8-K 8-K CURRENT REPORT DATED JULY 28, 2010 5.07 0001023175-10-000216 000-50547 10986693 34 8118
2010-06-23 10-K ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED MARCH 31, 2010 0001023175-10-000181 000-50547 10912451 34 421784
2010-02-05 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE PERIOD ENDED DECEMBER 31, 2009 0001023175-10-000024 000-50547 10577930 34 215958
2009-10-26 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED SEPTEMBER 30, 2009 0001010412-09-000250 000-50547 091136282 34 173092
2009-08-11 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE PERIOD ENDED JUNE 30, 2009 0001023175-09-000227 000-50547 091003294 34 173915
2009-06-29 10-K ANNUAL REPORT ON FORM 10K FOR THE FISCAL YEAR ENDED MARCH 31, 2009 0001023175-09-000197 000-50547 09915510 34 366470
2009-03-24 3 PRIMARY DOCUMENT 0001010412-09-000043 3081
2009-02-11 8-K f8kfinal.htm 5.02 0001023175-09-000041 000-50547 09589290 34 15867
2009-01-30 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE PERIOD ENDED DECEMBER 31, 2008 0001023175-09-000033 000-50547 09559381 34 173587
2008-10-29 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE PERIOD ENDED SEPTEMBER 30, 2008 0001023175-08-000192 000-50547 081146999 34 185915
2008-08-12 10-Q QUARTERLY REPORT ON FORM 10Q FOR THE PERIOD ENDED JUNE 30, 2008 0001023175-08-000135 000-50547 081009873 34 172249
2008-06-26 10-K ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED MARCH 31, 2008 0001023175-08-000105 000-50547 08918765 34 436489
2008-04-03 SC 13D SCHEDULE 13D FOR DAVID W. WEST 0001010412-08-000107 005-81838 08737241 34 17996
2008-03-18 4 PRIMARY DOCUMENT 0001010412-08-000075 4880
2008-03-18 4 PRIMARY DOCUMENT 0001010412-08-000074 4814
2008-03-18 3 PRIMARY DOCUMENT 0001010412-08-000073 4017
2008-03-12 3 PRIMARY DOCUMENT 0001010412-08-000058 3898
2008-03-12 4 PRIMARY DOCUMENT 0001010412-08-000057 4828
2008-03-12 8-K f8knoteconversionsprivateoff.htm 3.02,5.02 0001010412-08-000055 000-50547 08683306 34 15436
2008-02-13 10QSB QUARTERLY REPORT ON FORM 10-QSB FOR THE QUARTER ENDED DECEMBER 31, 2007 0001023175-08-000014 000-50547 08605554 34 200034
2007-10-29 10QSB QUARTERLY REPORT ON FORM 10QSB FOR THE PERIOD ENDED SEPTEMBER 30, 2007 0001023175-07-000233 000-50547 071195121 34 234066
2007-08-03 10QSB QUARTERLY REPORT ON FORM 10-QSB FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2007 0001023175-07-000159 000-50547 071022353 34 194441
2007-06-07 10KSB MARCH 31, 2007 10-KSB 0001078782-07-000598 000-50547 07906529 34 364580
2007-02-01 10QSB f06dectform10qsbjavafinal.htm 0001023175-07-000010 000-50547 07569961 34 193501
2006-10-30 SC 13D formsc13djaykirchrevised.htm 0001023175-06-000308 005-81838 061172553 34 20302
2006-10-30 SC 13D formsc13drevisedchriskirch.htm 0001023175-06-000307 005-81838 061172542 34 21016
2006-10-27 10QSB QUARTERLY REPORT ON FORM 10QSB FOR THE QUARTERLY PERIOD ENDED SEPTEMBE 30, 2006 0001023175-06-000305 000-50547 061168907 34 191595
2006-09-29 8-K f06sept27form8java.htm 4.01,9.01 0001023175-06-000295 000-50547 061118018 34 18668
2006-08-08 10QSB QUARTERLY REPORT ON FORM 10-QSB FOR THE PERIOD ENDED JUNE 30, 2006 0001023175-06-000237 000-50547 061012635 34 77413
2006-07-13 10KSB ANNUAL REPORT ON FORM 10-KSB FOR THE YEAR ENDED MARCH 31, 2006 0001023175-06-000221 000-50547 06960735 34 122213
2006-06-29 NT 10-K javalate.txt 0001023175-06-000210 000-50547 06932934 34 7451
2006-06-22 SC 13D formsc13dsansom.txt 0001023175-06-000207 005-81838 06918884 34 10693
2006-06-22 3 PRIMARY DOCUMENT 0001023175-06-000206 3680
2006-06-13 4 PRIMARY DOCUMENT 0001023175-06-000197 4573
2006-06-01 8-K java8k.txt 5.02 0001023175-06-000181 000-50547 06879875 34 4688
2006-05-31 SC 13D trimble.txt 0001023175-06-000178 005-81838 06876564 34 11333
2006-05-31 3 PRIMARY DOCUMENT 0001023175-06-000177 4431
2006-05-25 4 PRIMARY DOCUMENT 0001023175-06-000173 4573
2006-02-14 10QSB java10qsb.txt 0001023175-06-000048 000-50547 06611886 34 80246
2005-11-16 10QSB java10qsb.txt 0001023175-05-000264 000-50547 051209202 34 69520
2005-11-14 NT 10-Q javaseptlate.txt 0001023175-05-000253 000-50547 051200502 34 7435
2005-08-12 10QSB javaexpress10qsb.txt 0001023175-05-000169 000-50547 051020591 34 64742
2005-06-28 10KSB java10ksb.txt 0001023175-05-000138 000-50547 05919176 34 104458
2005-02-14 10QSB java10qsb.txt 0001023175-05-000014 000-50547 05608243 34 59072
2004-12-15 3 PRIMARY DOCUMENT 0001023175-04-000260 3665
2004-12-06 10QSB SEPTEMBER 30, 2004 10-QSB 0001078782-04-000311 000-50547 041185057 34 360209
2004-11-15 NT 10-Q javalatenotice.txt 0001023175-04-000241 000-50547 041144177 34 7570
2004-10-05 8-K FORM 8-K DATED 10-4-04 2.01,9.01 0001078782-04-000247 000-50547 041063677 158445
2004-08-09 10QSB java10q.txt 0001023175-04-000137 000-50547 04960622 66707
2004-07-14 10KSB java10k.txt 0001023175-04-000125 000-50547 04913563 128230
2004-06-29 NT 10-K javalatenotice.txt 0001023175-04-000122 000-50547 04888867 6890
2004-06-10 10QSB/A java10qsb.txt 0001023175-04-000117 000-50547 04856718 45768
2004-06-10 10SB12G/A javaform10a2.txt 0001023175-04-000116 000-50547 04856715 124108
2004-03-25 3 PRIMARY DOCUMENT 0001023175-04-000061 3784
2004-03-25 3 PRIMARY DOCUMENT 0001023175-04-000060 3780
2004-03-25 10QSB/A java10qsba.txt 0001023175-04-000059 000-50547 04689397 41014
2004-03-25 10SB12G/A javaform10a1.txt 0001023175-04-000058 000-50547 04689395 119918
2004-02-17 10QSB form10qsb123103.txt 0000939802-04-000051 000-50547 04606405 40812
2004-01-12 10SB12G javaform10.txt 0001023175-04-000003 000-50547 04521116 188653
2003-03-03 REGDEX AUTO-GENERATED PAPER DOCUMENT 04 9999999997-03-007075 021-53239 03016227 1513
2002-11-26 RW REQUEST FOR WITHDRAWAL OF REGISTRATION STATEMENT 0001078782-02-000252 333-87108 02840652 3657
2002-09-19 SB-2/A javasb2a3.txt 0001023175-02-000203 333-87108 02767898 197798
2002-07-17 SB-2/A javasb2a.txt 0001023175-02-000148 333-87108 02704559 166398
2002-05-03 SB-2/A javasb2amend.txt 0001023175-02-000090 333-87108 02633915 148839
2002-04-26 SB-2 javasb2.txt 0001023175-02-000085 333-87108 02623486 228115

Latest XBRL company facts

One latest value per concept from companyfacts (368 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 43.06M 2026-11-16 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0.001 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
dei EntityPublicFloat Entity Public Float USD 6.73M 2025-09-30 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 55,508 2018-09-30 2019 Q2 10-Q 2019-11-15 0001493152-19-017692
us-gaap AccountsPayableAndAccruedLiabilitiesNoncurrent Accounts Payable and Accrued Liabilities, Noncurrent USD 1.34M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 468,183 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 451,372 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.37M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 239,466 2019-12-31 2020 Q3 10-Q 2020-02-19 0001493152-20-002708
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 33.17M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 24.55M 2017-06-30 2018 Q1 10-Q 2019-04-08 0000891092-19-004397
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 388,511 2025-04-01 2025-06-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition USD 139,251 2013-04-01 2014-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 18,480 2021-07-01 2021-09-30 2023 Q3 10-Q 2023-02-14 0001493152-23-004805
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 182,572 2016-04-01 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 841,651 2013-04-01 2014-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 10,173 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 18,480 2021-07-01 2021-09-30 2022 Q3 10-Q 2022-02-14 0001493152-22-004540
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 7,950 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 52,980 2022-04-01 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004805
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 18.23M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap Assets Assets USD 21,805 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap AssetsCurrent Assets, Current USD 21,805 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap AssetsNoncurrent Assets, Noncurrent USD 32.65M 2016-12-31 2017 Q3 10-Q 2017-04-17 0001580957-17-000296
us-gaap BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired pure 1 2004-09-29 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap Cash Cash USD 32,035 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 6,245 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 3,955 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 53,943 2017-04-01 2017-12-31 2018 Q3 10-Q 2019-04-25 0001493152-19-005960
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 3,955 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 329,860 2024-03-31 2024 FY 10-K 2024-07-01 0001493152-24-025765
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -28,080 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 0 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/warrants 5 2014-03-31 2014 FY 10-K 2014-07-21 0001010412-14-000126
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.05 2022-06-20 2024 Q1 10-Q 2023-08-14 0001493152-23-028534
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 50,000 2021-07-29 2022 Q2 10-Q 2021-11-15 0001493152-21-028498
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.11M 2024-03-31 2024 FY 10-K 2024-07-01 0001493152-24-025765
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 4.49M 2021-06-30 2021 Q1 10-Q 2021-08-16 0001493152-21-020217
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 43.06M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 43.06M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued shares 140,000 2014-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 700,000 2014-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 654,500 2013-12-31 2013 Q3 10-Q 2014-02-14 0001010412-14-000019
us-gaap CommonStockValue Common Stock, Value, Issued USD 43,064 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 700,000 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 700,000 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap CostOfRevenue Cost of Revenue USD 45,400 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 200 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 200 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap CustomerAdvancesCurrent Customer Advances, Current USD 4,000 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 1.50M 2015-04-01 2016-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 240,055 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 1.11M 2014-11-20 2015 FY 10-K 2015-06-15 0001010412-15-000084
us-gaap DebtInstrumentConvertibleNumberOfEquityInstruments Debt Instrument, Convertible, Number of Equity Instruments item 187,500 2015-04-01 2015-06-30 2016 Q2 10-Q 2015-11-10 0001548123-15-000377
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 849,935 2018-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.08 2021-04-06 2025 Q2 10-Q 2024-11-08 0001493152-24-044334
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 64,000 2021-04-01 2021-09-30 2022 Q2 10-Q 2021-11-15 0001493152-21-028498
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 29,822 2022-02-07 2023 FY 10-K 2023-06-29 0001493152-23-022963
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -691,824 2017-04-01 2018-03-31 2019 FY 10-K 2020-01-16 0001493152-20-000649
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -758,972 2017-04-01 2018-03-31 2019 FY 10-K 2020-01-16 0001493152-20-000649
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 758,972 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap DeferredOtherTaxExpenseBenefit Deferred Other Tax Expense (Benefit) USD -1.13M 2015-04-01 2016-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -67,148 2017-04-01 2018-03-31 2019 FY 10-K 2020-01-16 0001493152-20-000649
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 9.43M 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 4.04M 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 8.24M 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 32.32M 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 40,814 2013-03-31 2012 FY 10-K 2013-07-16 0001010412-13-000195
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.12M 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 58,201 2025-03-31 2025 FY 10-K 2025-06-30 0001641172-25-017143
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 72,422 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 9.43M 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 758,972 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap DeferredTaxLiabilitiesCurrent Deferred Tax Liabilities, Net, Current USD 758,972 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap DeferredTaxLiabilitiesInvestments Deferred Tax Liabilities, Investments USD 4.80M 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 758,972 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap Depreciation Depreciation USD 26,606 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap DerivativeAssetNotionalAmount Derivative Asset, Notional Amount USD 36.80M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 20,050 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 0 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004805
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.01 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.01 2021-04-01 2021-12-31 2022 Q3 10-Q 2022-02-14 0001493152-22-004540
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.01 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.201 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent pure 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.009 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 182,572 2016-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap EquityIssuancePerShareAmount Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) USD 5 2013-04-01 2013-12-31 2013 Q3 10-Q 2014-02-14 0001010412-14-000019
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 1.49M 2015-03-01 2015-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap FairValueInputsDiscountRate Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) pure 0.15 2016-04-01 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD -40,814 2013-01-31 2013-03-31 2012 FY 10-K 2013-07-16 0001010412-13-000195
us-gaap FinancialInstrumentsOwnedAtFairValue Financial Instruments, Owned, at Fair Value USD 45.64M 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap FinancialInstrumentsSubjectToMandatoryRedemptionRedeemableWithinOneYear Financial Instrument Subject to Mandatory Redemption, Maturity, Year One USD 750,000 2016-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap FinancingInterestExpense Financing Interest Expense USD 15,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD -23,019 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 6,754 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 290,000 2023-04-01 2024-03-31 2025 FY 10-K 2025-06-30 0001641172-25-017143
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -388,511 2025-04-01 2025-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 195,253 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap GrossProfit Gross Profit USD 159,063 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap HeldToMaturitySecurities Debt Securities, Held-to-maturity USD 34.16M 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain USD 11.49M 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss USD 389,269 2016-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap HeldToMaturitySecuritiesFairValue Debt Securities, Held-to-maturity, Fair Value USD 45.64M 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap ImpairmentOfInvestments Other than Temporary Impairment Losses, Investments USD 17,840 2018-04-01 2019-03-31 2020 FY 10-K 2020-08-11 0001493152-20-015137
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -1.81M 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -403,906 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -1.70M 2018-04-01 2018-12-31 2019 Q3 10-Q 2019-11-25 0001493152-19-018382
us-gaap IncomeTaxesPaid Income Taxes Paid USD 200 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 200 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 200 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 200 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 364,655 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 3.12M 2017-04-01 2018-03-31 2019 FY 10-K 2020-01-16 0001493152-20-000649
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -436,789 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-30 0001641172-25-017143
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -380,890 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 6,616 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-29 0001493152-21-015565
us-gaap IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount USD 10 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 16,267 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 8,203 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 158 2025-04-01 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 16,811 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 135,420 2013-04-01 2014-03-31 2014 FY 10-K 2014-07-21 0001010412-14-000126
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 6,000 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -758,972 2017-04-01 2017-12-31 2019 Q3 10-Q 2019-11-25 0001493152-19-018382
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 2,204 2016-04-01 2016-06-30 2018 Q1 10-Q 2019-04-08 0000891092-19-004397
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 234,666 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 98,378 2013-02-01 2013-12-31 2013 Q3 10-Q 2014-02-14 0001010412-14-000019
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 2,205 2016-04-01 2016-09-30 2017 Q2 10-Q 2016-11-09 0001580957-16-000932
us-gaap IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet Increase (Decrease) in Other Current Assets and Liabilities, Net USD 28,600 2014-04-01 2014-09-30 2016 Q2 10-Q 2015-11-10 0001548123-15-000377
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 2,205 2016-04-01 2016-12-31 2017 Q3 10-Q 2017-04-17 0001580957-17-000296
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 1.45M 2016-04-01 2016-06-30 2018 Q1 10-Q 2019-04-08 0000891092-19-004397
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 8,401 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -2,500 2017-04-01 2017-06-30 2018 Q1 10-Q 2019-04-08 0000891092-19-004397
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 1.35M 2016-04-01 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap InterestExpense Interest Expense USD 410,856 2023-04-01 2024-03-31 2024 FY 10-K 2024-07-01 0001493152-24-025765
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 208,653 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap InterestIncomeOperating Interest Income, Operating USD 5.75M 2016-04-01 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap InterestIncomeOther Interest Income, Other USD 13,388 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-17 0001010412-15-000030
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 415,519 2017-04-01 2017-06-30 2018 Q1 10-Q 2019-04-08 0000891092-19-004397
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 150,000 2024-04-01 2025-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap InterestPayableCurrent Interest Payable, Current USD 124,225 2024-09-30 2025 Q2 10-Q 2024-11-08 0001493152-24-044334
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 453,569 2024-09-30 2025 Q2 10-Q 2024-11-08 0001493152-24-044334
us-gaap InterestReceivable Interest Receivable USD 11,638 2021-09-30 2022 Q2 10-Q 2021-11-15 0001493152-21-028498
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 5,241 2015-04-01 2016-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 139,251 2013-04-01 2013-12-31 2015 Q3 10-Q 2015-02-17 0001010412-15-000030
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 18,938 2013-04-01 2013-12-31 2013 Q3 10-Q 2014-02-14 0001010412-14-000019
us-gaap Liabilities Liabilities USD 7.52M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 21,805 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 15,195 2013-01-31 2013-03-31 2014 FY 10-K 2014-07-21 0001010412-14-000126
us-gaap LiabilitiesCurrent Liabilities, Current USD 3.75M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 3.77M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap LiabilityForFuturePolicyBenefits Liability for Future Policy Benefit, before Reinsurance USD 316,667 2018-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap LiabilityForFuturePolicyBenefitsLife Liability for Future Policy Benefits, Life USD 220,601 2017-09-30 2018 Q2 10-Q 2019-04-25 0001493152-19-005959
us-gaap LiabilityForFuturePolicyBenefitsPaymentForBenefits Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment USD 189,163 2017-04-01 2018-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap LifeSettlementContractsFairValueMethodFaceValue Life Settlement Contracts, Fair Value Method, Face Value USD 42.50M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearFive Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Rolling Year Five USD 24.50M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearFour Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Rolling Year Four USD 7.22M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearThree Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Rolling Year Three USD 0 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsFairValueMethodFaceValueMaturingInRollingYearTwo Life Settlement Contracts, Fair Value Method, Face Value, Maturing in Rolling Year Two USD 8.00M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFive Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Five USD 24.50M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsFairValueMethodFaceValueMaturingInYearFour Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Four USD 10.00M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsFairValueMethodFaceValueMaturingInYearThree Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Three USD 0 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsFairValueMethodFaceValueMaturingInYearTwo Life Settlement Contract, Fair Value Method, Face Value, Maturity, Year Two USD 8.00M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsFairValueMethodNumberOfContracts Life Settlement Contracts, Fair Value Method, Number of Contracts item 5 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFive Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Five item 3 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearFour Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Four item 1 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearThree Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Three item 0 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsFairValueMethodNumberOfContractsMaturingInYearTwo Life Settlement Contract, Fair Value Method, Number of Contracts, Maturity, Year Two item 1 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodCarryingAmount Life Settlement Contracts, Investment Method, Carrying Amount USD 34.16M 2017-03-31 2019 Q1 10-Q 2019-10-24 0001493152-19-015907
us-gaap LifeSettlementContractsInvestmentMethodFaceValue Life Settlement Contracts, Investment Method, Face Value USD 373.34M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodFaceValueMaturingAfterYearFive Life Settlement Contract, Investment Method, Face Value, Maturity, after Year Five USD 184.81M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodFaceValueMaturingInNextTwelveMonths Life Settlement Contract, Investment Method, Face Value, Maturity, Year One USD 34.59M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFive Life Settlement Contract, Investment Method, Face Value, Maturity, Year Five USD 35.44M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearFour Life Settlement Contract, Investment Method, Face Value, Maturity, Year Four USD 49.44M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearThree Life Settlement Contract, Investment Method, Face Value, Maturity, Year Three USD 37.44M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodFaceValueMaturingInYearTwo Life Settlement Contract, Investment Method, Face Value, Maturity, Year Two USD 31.61M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodFiveYearDisclosurePremiumsToBePaid Life Settlement Contracts, Investment Method, Premiums to be Paid USD 94.30M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodNumberOfContracts Life Settlement Contracts, Investment Method, Number of Contracts item 69 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingAfterYearFive Life Settlement Contract, Investment Method, Number of Contracts, Maturity, after Year Five item 30 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInNextTwelveMonths Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year One item 9 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFive Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Five item 6 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearFour Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Four item 11 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearThree Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Three item 7 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodNumberOfContractsMaturingInYearTwo Life Settlement Contract, Investment Method, Number of Contracts, Maturity, Year Two item 6 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodPremiumsToBePaidAfterYearFive Life Settlement Contract, Investment Method, Premium to be Paid, after Year Five USD 25.51M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodPremiumsToBePaidInNextTwelveMonths Life Settlement Contract, Investment Method, Premium to be Paid, Year One USD 14.72M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearFive Life Settlement Contract, Investment Method, Premium to be Paid, Year Five USD 11.94M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearFour Life Settlement Contract, Investment Method, Premium to be Paid, Year Four USD 13.60M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearThree Life Settlement Contract, Investment Method, Premium to be Paid, Year Three USD 13.46M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LifeSettlementContractsInvestmentMethodPremiumsToBePaidInYearTwo Life Settlement Contract, Investment Method, Premium to be Paid, Year Two USD 15.07M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap LineOfCredit Long-term Line of Credit USD 4.72M 2017-06-30 2018 Q1 10-Q 2019-04-08 0000891092-19-004397
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 2.00M 2013-11-05 2013 Q2 10-Q 2013-11-14 0001010412-13-000280
us-gaap LineOfCreditFacilityCurrentBorrowingCapacity Line of Credit Facility, Current Borrowing Capacity USD 55,000 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 5.90M 2018-06-30 2019 Q1 10-Q 2019-10-24 0001493152-19-015907
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 4.13M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap LoanProcessingFee Loan Processing Fee USD 180,000 2014-04-01 2015-03-31 2015 FY 10-K 2015-06-15 0001010412-15-000084
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 2.13M 2016-12-31 2017 Q3 10-Q 2017-04-17 0001580957-17-000296
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 2.46M 2025-03-31 2025 FY 10-K 2025-06-30 0001641172-25-017143
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 74,255 2014-04-01 2014-05-13 2015 FY 10-K 2015-06-15 0001010412-15-000084
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 125,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -496,269 2017-04-01 2017-06-30 2018 Q1 10-Q 2019-04-08 0000891092-19-004397
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 439,006 2015-04-01 2016-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 439,006 2015-04-01 2015-12-31 2017 Q3 10-Q 2017-04-17 0001580957-17-000296
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -153,080 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 527,083 2017-04-01 2017-06-30 2018 Q1 10-Q 2019-04-08 0000891092-19-004397
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -404,106 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -208,653 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap NotesAndLoansReceivableGrossCurrent Financing Receivable, before Allowance for Credit Loss, Current USD 150,000 2014-12-04 2015 FY 10-K 2015-06-15 0001010412-15-000084
us-gaap NotesPayable Notes Payable USD 4.27M 2023-12-31 2024 Q3 10-Q 2024-02-14 0001493152-24-006487
us-gaap NotesPayableCurrent Notes Payable, Current USD 300,000 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004805
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 717,058 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004805
us-gaap NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties USD 3.11M 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004805
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 2.24M 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004805
us-gaap NotesReceivableNet Financing Receivable, after Allowance for Credit Loss USD 211,000 2015-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap NotesReduction Notes Reduction USD 100,000 2014-04-01 2015-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap OperatingExpenses Operating Expenses USD 33,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -195,253 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 112,956 2015-04-01 2016-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 32.32M 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 631,485 2020-12-31 2021 Q3 10-Q 2021-02-16 0001493152-21-003741
us-gaap OtherAssetsCurrent Other Assets, Current USD 28,600 2014-09-30 2015 Q2 10-Q 2014-11-14 0001010412-14-000185
us-gaap OtherAssetsMiscellaneousNoncurrent Other Assets, Miscellaneous, Noncurrent USD 2,205 2016-12-31 2017 Q3 10-Q 2017-04-17 0001580957-17-000296
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 3.60M 2015-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap OtherCommitment Other Commitment USD 316,667 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 4,000 2013-12-31 2013 Q3 10-Q 2014-02-14 0001010412-14-000019
us-gaap OtherLongTermDebt Other Long-term Debt USD 2.03M 2021-12-31 2022 Q3 10-Q 2022-02-14 0001493152-22-004540
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 2,300 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 6,303 2014-04-01 2015-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap OtherNotesPayable Other Notes Payable USD 12.00M 2015-06-30 2016 Q1 10-Q 2015-08-10 0001010412-15-000125
us-gaap OtherRestrictedAssetsNoncurrent Other Restricted Assets, Noncurrent USD 100,000 2016-12-31 2017 Q3 10-Q 2017-04-17 0001580957-17-000296
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationGiven1 Other Significant Noncash Transaction, Value of Consideration Given USD 27,433 2001-12-14 2012-09-30 2012 Q2 10-Q/A 2012-11-13 0001078782-12-002793
us-gaap PaymentsForAdvanceToAffiliate Payments for Advance to Affiliate USD 100,000 2016-04-01 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap PaymentsForProceedsFromLoansReceivable Payments for (Proceeds from) Loans Receivable USD -211,000 2015-04-01 2016-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 750,000 2015-04-01 2016-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 40,211 2022-01-05 2023 FY 10-K 2023-06-29 0001493152-23-022963
us-gaap PaymentsOfLoanCosts Payments of Loan Costs USD 100,000 2016-04-01 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 841,651 2013-04-01 2014-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 24.00M 2015-04-01 2015-06-30 2016 Q1 10-Q 2015-08-10 0001010412-15-000125
us-gaap PaymentsToAcquireFurnitureAndFixtures Payments to Acquire Furniture and Fixtures USD 23,088 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 3.37M 2015-04-01 2015-12-31 2016 Q3 10-Q 2016-02-09 0000912282-16-000555
us-gaap PaymentsToAcquireLifeInsurancePolicies Payment to Acquire Life Insurance Policy, Investing Activities USD 626,914 2015-04-01 2016-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap PaymentsToAcquireMachineryAndEquipment Payments to Acquire Machinery and Equipment USD 53,500 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 150,000 2014-04-01 2015-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap PremiumsReceivableAtCarryingValue Premiums Receivable, Net USD 120.70M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 13,500 2025-12-31 2026 Q3 10-Q 2026-02-17 0001493152-26-007030
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 17,850 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 2,205 2017-06-30 2018 Q1 10-Q 2019-04-08 0000891092-19-004397
us-gaap ProceedsFromCollectionOfLoansReceivable Proceeds from Collection of Loans Receivable USD 211,000 2015-04-01 2015-12-31 2017 Q3 10-Q 2017-04-17 0001580957-17-000296
us-gaap ProceedsFromCollectionOfLongtermLoansToRelatedParties Proceeds from Collection of Long-term Loans to Related Parties USD 100,000 2014-04-01 2014-06-30 2015 Q1 10-Q 2014-08-14 0001010412-14-000139
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 200,000 2017-04-01 2018-03-31 2019 FY 10-K 2020-01-16 0001493152-20-000649
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 850,000 2023-04-01 2024-03-31 2024 FY 10-K 2024-07-01 0001493152-24-025765
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 26,458 2020-04-01 2021-03-31 2022 FY 10-K 2022-06-29 0001493152-22-018095
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 1.50M 2023-08-15 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 11.18M 2025-04-01 2025-09-30 2026 Q2 10-Q 2025-11-13 0001493152-25-022380
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 805,000 2024-04-01 2025-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap ProceedsFromLifeInsurancePolicies Proceeds from Life Insurance Policy USD 854,920 2015-04-01 2016-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 25,000 2025-04-01 2025-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 26,458 2020-04-01 2020-09-30 2022 Q2 10-Q 2021-11-15 0001493152-21-028498
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 700,000 2013-04-01 2014-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 12,942 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 125,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 112,000 2022-04-01 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004805
us-gaap ProceedsFromSaleAndMaturityOfOtherInvestments Proceeds from Sale and Maturity of Other Investments USD 7.30M 2017-04-01 2017-12-31 2018 Q3 10-Q 2019-04-25 0001493152-19-005960
us-gaap ProceedsFromSaleOfMachineryAndEquipment Proceeds from Sale of Machinery and Equipment USD 18,390 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 3.31M 2017-04-01 2018-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 12.75M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap ProfessionalFees Professional Fees USD 387,754 2013-02-01 2013-12-31 2013 Q3 10-Q 2014-02-14 0001010412-14-000019
us-gaap ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock Receivable from Shareholders or Affiliates for Issuance of Capital Stock USD 1,500 2014-03-31 2015 FY 10-K 2015-06-15 0001010412-15-000084
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 90,000 2013-04-01 2014-03-31 2014 FY 10-K 2014-07-21 0001010412-14-000126
us-gaap RelatedPartyTransactionRate Related Party Transaction, Rate pure 0.075 2018-04-01 2018-06-30 2019 Q1 10-Q 2019-10-24 0001493152-19-015907
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 900,000 2017-04-01 2018-03-31 2019 FY 10-K 2020-01-16 0001493152-20-000649
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 5,748 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 50,000 2024-04-01 2025-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap RestructuringAndRelatedCostIncurredCost Restructuring and Related Cost, Incurred Cost USD 4.00M 2015-04-01 2015-06-30 2016 Q1 10-Q 2015-08-10 0001010412-15-000125
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -40.72M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap Revenues Revenues USD 204,463 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap SaleOfStockPercentageOfOwnershipAfterTransaction Sale of Stock, Percentage of Ownership after Transaction pure 0.4 2021-04-01 2022-03-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004805
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 153,821 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 73,920 2021-04-01 2022-03-31 2023 FY 10-K 2023-06-29 0001493152-23-022963
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage pure 0.1 2013-10-01 2013-10-11 2013 Q2 10-Q 2013-11-14 0001010412-13-000280
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 70,000 2015-04-01 2016-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 1.92 2015-04-01 2016-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 70,000 2013-04-01 2014-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.92 2013-04-01 2014-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 1.92 2015-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 70,000 2014-04-01 2015-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 1.92 2014-04-01 2015-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2022-01-05 2023 FY 10-K 2023-06-29 0001493152-23-022963
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.318 2022-01-05 2023 FY 10-K 2023-06-29 0001493152-23-022963
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.44 2022-10-01 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004805
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 1.422 2022-10-01 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004805
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.014 2022-01-05 2023 FY 10-K 2023-06-29 0001493152-23-022963
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.043 2022-10-01 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004805
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations shares 270,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted shares 250,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 18.23M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 3.81M 2018-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.11M 2018-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 1.57 2018-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 78,125 2015-04-01 2016-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 0.77 2015-04-01 2016-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.71M 2018-04-01 2018-09-30 2019 Q2 10-Q 2019-11-15 0001493152-19-017692
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value USD/shares 3.37M 2013-04-01 2014-03-31 2014 FY 10-K 2014-07-21 0001010412-14-000126
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.19M 2013-04-01 2014-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.91 2013-04-01 2014-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 3.31M 2016-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 0 2019-09-30 2020 Q2 10-Q 2020-02-19 0001493152-20-002706
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 1.57 2018-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 2.93M 2016-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 2.11M 2017-06-30 2018 Q1 10-Q 2019-04-08 0000891092-19-004397
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 1.57 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 3.31M 2017-06-30 2018 Q1 10-Q 2019-04-08 0000891092-19-004397
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 2.11M 2018-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 1.57 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 1.04 2016-04-01 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 400,000 2013-10-01 2013-10-11 2013 Q2 10-Q 2013-11-14 0001010412-13-000280
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.54 2013-04-01 2014-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionCashFlowEffects Share-based Goods and Nonemployee Services Transaction, Cash Flow Effects (Deprecated 2013-01-31) USD 98 2001-12-14 2012-12-31 2012 Q3 10-Q 2013-02-14 0001078782-13-000317
us-gaap SharePrice Share Price USD/shares 1.049 2022-01-05 2023 FY 10-K 2023-06-29 0001493152-23-022963
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -7.50M 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap StockIssued1 Stock Issued USD 7.54M 2014-04-01 2015-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 3.76M 2013-01-31 2013-03-31 2012 FY 10-K 2013-07-16 0001010412-13-000195
us-gaap StockIssuedDuringPeriodSharesIssuedForCash Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) shares 1.46M 2013-04-01 2013-12-31 2013 Q3 10-Q 2014-02-14 0001010412-14-000019
us-gaap StockIssuedDuringPeriodSharesIssuedForNoncashConsideration Development Stage Entities, Stock Issued, Shares, Issued for Noncash Consideration (Deprecated 2015-01-31) shares 37.04M 2013-01-31 2013-03-31 2012 FY 10-K 2013-07-16 0001010412-13-000195
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 942,500 2015-06-08 2015-06-09 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares 2.36M 2013-04-01 2014-03-31 2016 FY 10-K 2016-06-14 0001580957-16-000709
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 1.46M 2013-04-01 2013-09-30 2013 Q2 10-Q 2013-11-14 0001010412-13-000280
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 2.11M 2018-04-01 2019-03-31 2019 FY 10-K 2020-01-16 0001493152-20-000649
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD -15,195 2013-01-31 2013-03-31 2014 FY 10-K 2014-07-21 0001010412-14-000126
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 223,957 2007-04-01 2008-03-31 2011 FY 10-K 2012-07-16 0001078782-12-001796
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 7.32M 2013-04-01 2013-12-31 2013 Q3 10-Q 2014-02-14 0001010412-14-000019
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 6,244 2020-04-01 2021-03-31 2022 FY 10-K 2022-06-29 0001493152-22-018095
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 805,000 2024-04-01 2025-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 200,000 2023-07-01 2023-09-30 2024 Q2 10-Q 2023-11-14 0001493152-23-040910
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 7.32M 2013-04-01 2013-09-30 2013 Q2 10-Q 2013-11-14 0001010412-13-000280
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 73,920 2021-04-01 2022-03-31 2023 FY 10-K 2023-06-29 0001493152-23-022963
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 182,572 2016-04-01 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 8.00M 2018-12-05 2018-12-06 2024 Q1 10-Q 2023-08-14 0001493152-23-028534
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 93,750 2015-06-08 2015-06-09 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 300,000 2018-12-06 2025 Q1 10-Q 2024-08-13 0001493152-24-031412
us-gaap TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests USD 750,000 2015-09-30 2016 Q2 10-Q 2015-11-10 0001548123-15-000377
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2015-09-30 2016 Q2 10-Q 2015-11-10 0001548123-15-000377
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 8 2015-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 93,750 2015-09-30 2016 Q2 10-Q 2015-11-10 0001548123-15-000377
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 93,750 2015-09-30 2016 Q2 10-Q 2015-11-10 0001548123-15-000377
us-gaap TransferToInvestments Transfer to Investments USD 3.37M 2015-04-01 2016-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-03-31 2026 FY 10-K 2026-06-29 0001493152-26-031046
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2014-03-31 2014 FY 10-K 2014-07-21 0001010412-14-000126
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2022-04-01 2023-03-31 2023 FY 10-K 2023-06-29 0001493152-23-022963
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -275,000 2016-04-01 2016-12-31 2017 Q3 10-Q 2017-04-17 0001580957-17-000296
us-gaap VariableInterestEntityConsolidatedCarryingAmountAssets Variable Interest Entity, Consolidated, Carrying Amount, Assets (Deprecated 2020-01-31) USD 34.16M 2017-03-31 2017 FY 10-K 2018-04-12 0001580957-18-000172
us-gaap WarrantExercisePriceIncrease Warrant, Exercise Price, Increase USD/shares 1.05 2022-06-19 2022-06-20 2024 Q1 10-Q 2023-08-14 0001493152-23-028534
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 589,858 2022-12-31 2023 Q3 10-Q 2023-02-14 0001493152-23-004805
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 1.35M 2016-04-01 2017-03-31 2018 FY 10-K 2019-10-16 0001493152-19-015587
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 43.06M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 41.17M 2021-04-01 2021-12-31 2022 Q3 10-Q 2022-02-14 0001493152-22-004540
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 43.06M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-16 0001493152-26-052304

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →